Rho, Italy

Maco Torri



Average Co-Inventor Count = 10.0

ph-index = 1


Company Filing History:


Years Active: 2011

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Maco Torri

Introduction

Maco Torri is an accomplished inventor based in Rho, Italy. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds aimed at treating cardiovascular disorders. His work is characterized by a focus on innovative chemical derivatives that have the potential to improve patient outcomes.

Latest Patents

Maco Torri holds a patent for "Amino derivatives of beta-homoandrostanes and beta-heteroandrostanes." This patent describes new aminoalkoxyimino derivatives at position 3 of substituted beta-homoandrostanes and beta-heteroandrostanes. The processes for their preparation and the pharmaceutical compositions containing them are intended for the treatment of cardiovascular disorders, such as heart failure and hypertension. The compounds are defined by a general formula, where the radicals have specific meanings detailed in the application.

Career Highlights

Maco Torri is associated with Sigma-Tau Industrie Farmaceutiche Riunite S.p.A., a company known for its commitment to pharmaceutical innovation. His work at Sigma-Tau has allowed him to focus on developing new therapeutic solutions that address critical health issues.

Collaborations

Maco Torri has collaborated with notable colleagues, including Alberto Cerri and Barbara Moro. These partnerships have contributed to the advancement of his research and the successful development of his patented compounds.

Conclusion

Maco Torri's contributions to pharmaceutical innovation, particularly in cardiovascular treatments, highlight his role as a significant inventor in the field. His patented work demonstrates the potential for new chemical derivatives to improve health outcomes for patients suffering from serious conditions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…